A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers

Charles M. Zelen, Thomas E Serena, Guilhem Denozière, Donald Fetterolf

International Wound Journal · 2013 · 263 citations · 27 references

DOIFull text

Open access

Concepts

TL;DR

The study compared healing of diabetic foot ulcers treated with dehydrated human amniotic membrane allografts (EpiFix) to standard care. In a prospective, randomized, single‑centre trial, patients with non‑infected ulcers ≥4 weeks and adequate perfusion were randomized to standard care alone or with EpiFix, and wound size reduction and complete healing at 4 and 6 weeks were assessed. EpiFix produced markedly greater wound size reduction (≈97 % vs 32 % at 4 weeks, ≈98 % vs –1.8 % at 6 weeks) and higher healing rates (77 % and 92 % vs 0 % and 8 %) compared with standard care, demonstrating its efficacy.

Abstract

Abstract Our purpose was to compare healing characteristics of diabetic foot ulcers treated with dehydrated human amniotic membrane allografts ( EpiFix ®, MiMedx , Kennesaw, GA ) versus standard of care. An IRB ‐approved, prospective, randomised, single‐centre clinical trial was performed. Included were patients with a diabetic foot ulcer of at least 4‐week duration without infection having adequate arterial perfusion. Patients were randomised to receive standard care alone or standard care with the addition of EpiFix . Wound size reduction and rates of complete healing after 4 and 6 weeks were evaluated. In the standard care group ( n = 12) and the EpiFix group ( n = 13) wounds reduced in size by a mean of 32·0% ± 47·3% versus 97·1% ± 7·0% ( P < 0·001) after 4 weeks, whereas at 6 weeks wounds were reduced by −1·8% ± 70·3% versus 98·4% ± 5·8% ( P < 0·001), standard care versus EpiFix , respectively. After 4 and 6 weeks of treatment the overall healing rate with application of EpiFix was shown to be 77% and 92%, respectively, whereas standard care healed 0% and 8% of the wounds ( P < 0·001), respectively. Patients treated with EpiFix achieved superior healing rates over standard treatment alone. These results show that using EpiFix in addition to standard care is efficacious for wound healing.

References

27